BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31987787)

  • 1. HASPIN is involved in the progression of gallbladder carcinoma.
    Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
    Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer.
    Chen J; Yu Y; Li H; Hu Q; Chen X; He Y; Xue C; Ren F; Ren Z; Li J; Liu L; Duan Z; Cui G; Sun R
    Mol Cancer; 2019 Mar; 18(1):33. PubMed ID: 30825877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skp2-RNAi suppresses proliferation and migration of gallbladder carcinoma cells by enhancing p27 expression.
    Zhang B; Ji LH; Liu W; Zhao G; Wu ZY
    World J Gastroenterol; 2013 Aug; 19(30):4917-24. PubMed ID: 23946596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
    Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y
    Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of FoxM1 inhibits viability and invasion of gallbladder carcinoma cells, partially dependent on inducement of cellular senescence.
    Tao J; Xu XS; Song YZ; Qu K; Wu QF; Wang RT; Meng FD; Wei JC; Dong SB; Zhang YL; Tai MH; Dong YF; Wang L; Liu C
    World J Gastroenterol; 2014 Jul; 20(28):9497-505. PubMed ID: 25071344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mda-7/IL-24 induces apoptosis in human GBC-SD gallbladder carcinoma cells via mitochondrial apoptotic pathway.
    Jia J; Li S; Gong W; Ding J; Fang C; Quan Z
    Oncol Rep; 2011 Jan; 25(1):195-201. PubMed ID: 21109977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
    Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
    Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of tissue factor pathway inhibitor-2 gene in gallbladder cancer].
    Qin YY; Gong W; Weng MZ; Li JY; Quan ZW
    Zhonghua Wai Ke Za Zhi; 2012 Dec; 50(12):1099-103. PubMed ID: 23336488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells.
    Tan Z; Li M; Wu W; Zhang L; Ding Q; Wu X; Mu J; Liu Y
    Mol Cell Biochem; 2012 Oct; 369(1-2):27-33. PubMed ID: 22733362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
    Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
    J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
    Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
    Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
    Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
    Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
    Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
    Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
    Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer.
    Liu B; Shen ED; Liao MM; Hu YB; Wu K; Yang P; Zhou L; Chen WD
    Tumour Biol; 2016 Jul; 37(7):9875-86. PubMed ID: 26812694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy.
    Hu MT; Wang JH; Yu Y; Liu C; Li B; Cheng QB; Jiang XQ
    Int J Oncol; 2018 Sep; 53(3):1215-1226. PubMed ID: 30015925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
    Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOAT1 in gallbladder cancer: Clinicopathological significance and avasimibe therapeutics.
    Hong Y; Abudukeremu X; She F; Chen Y
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23733. PubMed ID: 38770938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.